35 results
8-K
EX-1.1
TRML
Tourmaline Bio Inc
26 Jan 24
Other Events
4:12pm
, or with the employees of any principal supplier, manufacturer, customer or contractor of the Company, exists or, to the knowledge of the Company, is threatened
8-K
EX-99.1
TRML
Tourmaline Bio Inc
24 Jan 24
Results of Operations and Financial Condition
5:10pm
as part of the supplier qualification program. We oversee CDMOs by performing technical and quality assurance review and/or approval of cGMP
424B3
ewnnk2q5o4vfl01
15 Sep 23
Prospectus supplement
6:31am
S-4/A
jm7m9ysd6te
25 Aug 23
Registration of securities issued in business combination transactions (amended)
4:34pm
S-4
p3qsdcpn3fm6mfkw
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
425
cn1kb3 b5cez5963
22 Jun 23
Business combination disclosure
9:12am
8-K
EX-2.1
xm7sipimy02eh
22 Jun 23
Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement
9:10am
S-3
EX-1.2
8mxtxdr dd8xkccjxt4
15 Aug 22
Shelf registration
5:06pm